1. CD4+CD45RA−FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin‐secreting capacity in patients with type 1 diabetes. (4th July 2013) Authors: Haseda, F.; Imagawa, A.; Murase‐Mishiba, Y.; Terasaki, J.; Hanafusa, T. Journal: Clinical and experimental immunology Issue: Volume 173:Number 2(2013:Aug.) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of ONO-8590580: A novel, potent and selective GABAA α5 negative allosteric modulator for the treatment of cognitive disorders. Issue 22 (15th November 2020) Authors: Lewis, A.; Beresford, A.; Chambers, M.S.; Clark, G.; Hartley, D.C.; Hirst, K.L.; Higashino, M.; Kawahadara, S.; Nakanishi, M.; Saito, T.; Imagawa, A.; Habashita, H.; Maidment, S.; Macleod, A.M.; Owens, A.P.; Rae, A.; Rouse, C.; Wishart, G. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 22(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide. (15th April 2008) Authors: Murase-Mishiba, Yuko; Imagawa, A.; Hanafusa, Toshiaki Other Names: Forst Thomas Academic Editor. Journal: Experimental diabetes research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low programmed cell death‐1 (PD‐1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes. (15th May 2015) Authors: Fujisawa, R.; Haseda, F.; Tsutsumi, C.; Hiromine, Y.; Noso, S.; Kawabata, Y.; Mitsui, S.; Terasaki, J.; Ikegami, H.; Imagawa, A.; Hanafusa, T. Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗